INVESTORS
We aspire to create value for society, our future business and shareholders
Every quarter, we share our financial results. Get all the details here.
Current and previous financial results, including annual reports, quarterly company announcements, investor presentations, financial workbooks, investor calls and webcasts.
17 January 2025
Novo Nordisk A/S: Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherence
Read more
08 January 2025
Valo Health and Novo Nordisk expand collaboration to discover and develop novel treatments for cardiometabolic diseases
Read more
20 December 2024
Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight in the REDEFINE 1 trial
Read more
Here is a list of current or upcoming conference calls for investors. You can watch live or after the event has taken place.
See key upcoming events in the financial calendar and stay informed by subscribing to company announcements and press releases.
Rewatch presentations and access materials from our latest Capital Markets Day.
Watch the recording of this year’s Annual General Meeting held on 21 March 2024 in Copenhagen.
Below are topics selected particularly for you as a private shareholder.
The Investor portal is for you as a Novo Nordisk shareholder. View your personal share information, register to receive Novo Nordisk Annual Report and Annual General Meeting notification, and change your contact information.
Here you will find information about the Novo Nordisk share, share tools and details about this year's dividend pay.
Related content
Investors
Share price